Signal Advisors Wealth’s GSK GSK Stock Holding History

Signal Advisors Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,922	Closed	-$597K	–	156
2024 Q1	$597K	Sell	13,922 -526	-4%	-$21.7K	0.15%	141
2023 Q4	$540K	Buy	+14,448	New	+$519K	0.19%	111

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Signal Advisors Wealth's GSK Position: Q2 2024 in Review

Signal Advisors Wealth sold out of GSK (GSK) in Q2 2024, closing a stake of 13,922 shares — an estimated $597K sold.

Signal Advisors Wealth first reported a position in GSK in Q4 2023 and held it in 2 quarters. The position peaked at $597K in Q1 2024. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

Signal Advisors Wealth reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
Signal Advisors Wealth sold 13,922 GSK shares in Q2 2024, an estimated $597K.
Signal Advisors Wealth first reported a position in GSK in Q4 2023 and held it in 2 quarters.
Signal Advisors Wealth's GSK position peaked at $597K in Q1 2024.
884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on Signal Advisors Wealth's 13F filing for Q2 2024, filed 23 Jul 2024.